Self-monitoring of Blood Pressure in Patients With Hypertension-Related Multi-morbidity: Systematic Review and Individual Patient Data Meta-analysis

Abstract BACKGROUND Studies have shown that self-monitoring of blood pressure (BP) is effective when combined with co-interventions, but its efficacy varies in the presence of some co-morbidities. This study examined whether self-monitoring can reduce clinic BP in patients with hypertension-related...

Full description

Saved in:

Bibliographic Details
Published in:	American journal of hypertension Vol. 33; no. 3; pp. 243 - 251
Main Authors:	Sheppard, J P, Tucker, K L, Davison, W J, Stevens, R, Aekplakorn, W, Bosworth, H B, Bove, A, Earle, K, Godwin, M, Green, B B, Hebert, P, Heneghan, C, Hill, N, Hobbs, F D R, Kantola, I, Kerry, S M, Leiva, A, Magid, D J, Mant, J, Margolis, K L, McKinstry, B, McLaughlin, M A, McNamara, K, Omboni, S, Ogedegbe, O, Parati, G, Varis, J, Verberk, W J, Wakefield, B J, McManus, R J
Format:	Journal Article
Language:	English
Published:	US Oxford University Press 13.03.2020
Subjects:	Aged Aged, 80 and over Blood Pressure Blood Pressure Monitoring, Ambulatory Female Humans Hypertension - diagnosis Hypertension - epidemiology Hypertension - physiopathology Hypertension - therapy Male Middle Aged Multimorbidity Predictive Value of Tests Prognosis Randomized Controlled Trials as Topic Risk Factors Self Care Time Factors blood pressure coronary heart disease diabetes hypertension stroke obesity randomized controlled trial
ISSN:	0895-7061, 1941-7225, 1941-7225
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Abstract	Abstract BACKGROUND Studies have shown that self-monitoring of blood pressure (BP) is effective when combined with co-interventions, but its efficacy varies in the presence of some co-morbidities. This study examined whether self-monitoring can reduce clinic BP in patients with hypertension-related co-morbidity. METHODS A systematic review was conducted of articles published in Medline, Embase, and the Cochrane Library up to January 2018. Randomized controlled trials of self-monitoring of BP were selected and individual patient data (IPD) were requested. Contributing studies were prospectively categorized by whether they examined a low/high-intensity co-intervention. Change in BP and likelihood of uncontrolled BP at 12 months were examined according to number and type of hypertension-related co-morbidity in a one-stage IPD meta-analysis. RESULTS A total of 22 trials were eligible, 16 of which were able to provide IPD for the primary outcome, including 6,522 (89%) participants with follow-up data. Self-monitoring was associated with reduced clinic systolic BP compared to usual care at 12-month follow-up, regardless of the number of hypertension-related co-morbidities (−3.12 mm Hg, [95% confidence intervals −4.78, −1.46 mm Hg]; P value for interaction with number of morbidities = 0.260). Intense interventions were more effective than low-intensity interventions in patients with obesity (P < 0.001 for all outcomes), and possibly stroke (P < 0.004 for BP control outcome only), but this effect was not observed in patients with coronary heart disease, diabetes, or chronic kidney disease. CONCLUSIONS Self-monitoring lowers BP regardless of the number of hypertension-related co-morbidities, but may only be effective in conditions such obesity or stroke when combined with high-intensity co-interventions.
AbstractList	Abstract BACKGROUND Studies have shown that self-monitoring of blood pressure (BP) is effective when combined with co-interventions, but its efficacy varies in the presence of some co-morbidities. This study examined whether self-monitoring can reduce clinic BP in patients with hypertension-related co-morbidity. METHODS A systematic review was conducted of articles published in Medline, Embase, and the Cochrane Library up to January 2018. Randomized controlled trials of self-monitoring of BP were selected and individual patient data (IPD) were requested. Contributing studies were prospectively categorized by whether they examined a low/high-intensity co-intervention. Change in BP and likelihood of uncontrolled BP at 12 months were examined according to number and type of hypertension-related co-morbidity in a one-stage IPD meta-analysis. RESULTS A total of 22 trials were eligible, 16 of which were able to provide IPD for the primary outcome, including 6,522 (89%) participants with follow-up data. Self-monitoring was associated with reduced clinic systolic BP compared to usual care at 12-month follow-up, regardless of the number of hypertension-related co-morbidities (−3.12 mm Hg, [95% confidence intervals −4.78, −1.46 mm Hg]; P value for interaction with number of morbidities = 0.260). Intense interventions were more effective than low-intensity interventions in patients with obesity (P < 0.001 for all outcomes), and possibly stroke (P < 0.004 for BP control outcome only), but this effect was not observed in patients with coronary heart disease, diabetes, or chronic kidney disease. CONCLUSIONS Self-monitoring lowers BP regardless of the number of hypertension-related co-morbidities, but may only be effective in conditions such obesity or stroke when combined with high-intensity co-interventions. Studies have shown that self-monitoring of blood pressure (BP) is effective when combined with co-interventions, but its efficacy varies in the presence of some co-morbidities. This study examined whether self-monitoring can reduce clinic BP in patients with hypertension-related co-morbidity. A systematic review was conducted of articles published in Medline, Embase, and the Cochrane Library up to January 2018. Randomized controlled trials of self-monitoring of BP were selected and individual patient data (IPD) were requested. Contributing studies were prospectively categorized by whether they examined a low/high-intensity co-intervention. Change in BP and likelihood of uncontrolled BP at 12 months were examined according to number and type of hypertension-related co-morbidity in a one-stage IPD meta-analysis. A total of 22 trials were eligible, 16 of which were able to provide IPD for the primary outcome, including 6,522 (89%) participants with follow-up data. Self-monitoring was associated with reduced clinic systolic BP compared to usual care at 12-month follow-up, regardless of the number of hypertension-related co-morbidities (-3.12 mm Hg, [95% confidence intervals -4.78, -1.46 mm Hg]; P value for interaction with number of morbidities = 0.260). Intense interventions were more effective than low-intensity interventions in patients with obesity (P < 0.001 for all outcomes), and possibly stroke (P < 0.004 for BP control outcome only), but this effect was not observed in patients with coronary heart disease, diabetes, or chronic kidney disease. Self-monitoring lowers BP regardless of the number of hypertension-related co-morbidities, but may only be effective in conditions such obesity or stroke when combined with high-intensity co-interventions. Studies have shown that self-monitoring of blood pressure (BP) is effective when combined with co-interventions, but its efficacy varies in the presence of some co-morbidities. This study examined whether self-monitoring can reduce clinic BP in patients with hypertension-related co-morbidity.BACKGROUNDStudies have shown that self-monitoring of blood pressure (BP) is effective when combined with co-interventions, but its efficacy varies in the presence of some co-morbidities. This study examined whether self-monitoring can reduce clinic BP in patients with hypertension-related co-morbidity.A systematic review was conducted of articles published in Medline, Embase, and the Cochrane Library up to January 2018. Randomized controlled trials of self-monitoring of BP were selected and individual patient data (IPD) were requested. Contributing studies were prospectively categorized by whether they examined a low/high-intensity co-intervention. Change in BP and likelihood of uncontrolled BP at 12 months were examined according to number and type of hypertension-related co-morbidity in a one-stage IPD meta-analysis.METHODSA systematic review was conducted of articles published in Medline, Embase, and the Cochrane Library up to January 2018. Randomized controlled trials of self-monitoring of BP were selected and individual patient data (IPD) were requested. Contributing studies were prospectively categorized by whether they examined a low/high-intensity co-intervention. Change in BP and likelihood of uncontrolled BP at 12 months were examined according to number and type of hypertension-related co-morbidity in a one-stage IPD meta-analysis.A total of 22 trials were eligible, 16 of which were able to provide IPD for the primary outcome, including 6,522 (89%) participants with follow-up data. Self-monitoring was associated with reduced clinic systolic BP compared to usual care at 12-month follow-up, regardless of the number of hypertension-related co-morbidities (-3.12 mm Hg, [95% confidence intervals -4.78, -1.46 mm Hg]; P value for interaction with number of morbidities = 0.260). Intense interventions were more effective than low-intensity interventions in patients with obesity (P < 0.001 for all outcomes), and possibly stroke (P < 0.004 for BP control outcome only), but this effect was not observed in patients with coronary heart disease, diabetes, or chronic kidney disease.RESULTSA total of 22 trials were eligible, 16 of which were able to provide IPD for the primary outcome, including 6,522 (89%) participants with follow-up data. Self-monitoring was associated with reduced clinic systolic BP compared to usual care at 12-month follow-up, regardless of the number of hypertension-related co-morbidities (-3.12 mm Hg, [95% confidence intervals -4.78, -1.46 mm Hg]; P value for interaction with number of morbidities = 0.260). Intense interventions were more effective than low-intensity interventions in patients with obesity (P < 0.001 for all outcomes), and possibly stroke (P < 0.004 for BP control outcome only), but this effect was not observed in patients with coronary heart disease, diabetes, or chronic kidney disease.Self-monitoring lowers BP regardless of the number of hypertension-related co-morbidities, but may only be effective in conditions such obesity or stroke when combined with high-intensity co-interventions.CONCLUSIONSSelf-monitoring lowers BP regardless of the number of hypertension-related co-morbidities, but may only be effective in conditions such obesity or stroke when combined with high-intensity co-interventions.
Author	Heneghan, C Magid, D J Stevens, R McLaughlin, M A Bove, A Tucker, K L Aekplakorn, W Sheppard, J P Hill, N Godwin, M Omboni, S Verberk, W J Hobbs, F D R Leiva, A Mant, J McNamara, K Green, B B Earle, K Ogedegbe, O Kantola, I Varis, J Davison, W J Bosworth, H B Parati, G Kerry, S M Wakefield, B J Hebert, P Margolis, K L McManus, R J McKinstry, B
Author_xml	– sequence: 1 givenname: J P orcidid: 0000-0002-4461-8756 surname: Sheppard fullname: Sheppard, J P organization: Nuffield Department of Primary Care, University of Oxford, Oxford, United Kingdom – sequence: 2 givenname: K L surname: Tucker fullname: Tucker, K L email: katherine.tucker@phc.ox.ac.uk organization: Nuffield Department of Primary Care, University of Oxford, Oxford, United Kingdom – sequence: 3 givenname: W J surname: Davison fullname: Davison, W J organization: Ageing and Stroke Medicine, Norwich Medical School, University of East Anglia, United Kingdom – sequence: 4 givenname: R surname: Stevens fullname: Stevens, R organization: Nuffield Department of Primary Care, University of Oxford, Oxford, United Kingdom – sequence: 5 givenname: W surname: Aekplakorn fullname: Aekplakorn, W organization: Department of Community Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University Bangkok, Thailand – sequence: 6 givenname: H B surname: Bosworth fullname: Bosworth, H B organization: Center for Health Services Research in Primary Care, Department of Population Health Sciences, Duke University, Durham, North Carolina, USA – sequence: 7 givenname: A surname: Bove fullname: Bove, A organization: Cardiology, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, USA – sequence: 8 givenname: K surname: Earle fullname: Earle, K organization: Thomas Addison Diabetes Unit, St. George’s University Hospitals NHS Foundation Trust, London, United Kingdom – sequence: 9 givenname: M surname: Godwin fullname: Godwin, M organization: Family Medicine, Memorial University of Newfoundland, St. John’s, Canada – sequence: 10 givenname: B B surname: Green fullname: Green, B B organization: Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA – sequence: 11 givenname: P surname: Hebert fullname: Hebert, P organization: Department of Health Services, University of Washington School of Public Health, Seattle, Washington, USA – sequence: 12 givenname: C surname: Heneghan fullname: Heneghan, C organization: Nuffield Department of Primary Care, University of Oxford, Oxford, United Kingdom – sequence: 13 givenname: N surname: Hill fullname: Hill, N organization: Nuffield Department of Primary Care, University of Oxford, Oxford, United Kingdom – sequence: 14 givenname: F D R surname: Hobbs fullname: Hobbs, F D R organization: Nuffield Department of Primary Care, University of Oxford, Oxford, United Kingdom – sequence: 15 givenname: I surname: Kantola fullname: Kantola, I organization: Division of Medicine, Turku University Hospital and University of Turku, Turku, Finland – sequence: 16 givenname: S M surname: Kerry fullname: Kerry, S M organization: Centre for Primary Care and Public Health, Queen Mary University of London, London, United Kingdom – sequence: 17 givenname: A surname: Leiva fullname: Leiva, A organization: Primary Care Research Unit of Mallorca, Baleares Health Services-IbSalut, Mallorca, Spain – sequence: 18 givenname: D J surname: Magid fullname: Magid, D J organization: Colorado School of Public Health, University of Colorado, Denver, Colorado, USA – sequence: 19 givenname: J surname: Mant fullname: Mant, J organization: Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom – sequence: 20 givenname: K L surname: Margolis fullname: Margolis, K L organization: HealthPartners Institute, Minneapolis, Minnesota, USA – sequence: 21 givenname: B surname: McKinstry fullname: McKinstry, B organization: Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, United Kingdom – sequence: 22 givenname: M A surname: McLaughlin fullname: McLaughlin, M A organization: Icahn School of Medicine at Mount Sinai New York, New York, New York, USA – sequence: 23 givenname: K surname: McNamara fullname: McNamara, K organization: Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, Australia – sequence: 24 givenname: S surname: Omboni fullname: Omboni, S organization: Clinical Research Unit, Italian Institute of Telemedicine, Varese, Italy – sequence: 25 givenname: O surname: Ogedegbe fullname: Ogedegbe, O organization: Center for Healthful Behavior Change, Division of Health and Behavior, Department of Population Health, Langone School of Medicine, New York University, New York, USA – sequence: 26 givenname: G surname: Parati fullname: Parati, G organization: Istituto Auxologico Italiano, IRCCS, Department of Cardiovascular, Neural and Metabolic Sciences, San Luca Hospital, Milan, Italy – sequence: 27 givenname: J surname: Varis fullname: Varis, J organization: Division of Medicine, Turku University Hospital and University of Turku, Turku, Finland – sequence: 28 givenname: W J surname: Verberk fullname: Verberk, W J organization: Cardiovascular Research Institute Maastricht and Departments of Internal Medicine, Maastricht University, Maastricht, The Netherlands – sequence: 29 givenname: B J surname: Wakefield fullname: Wakefield, B J organization: Department of Veterans (VA) Health Services Research and Development Centre for Comprehensive Access and Delivery Research and Evaluation (CADRE), VA Medical Centre, Iowa City, USA – sequence: 30 givenname: R J surname: McManus fullname: McManus, R J organization: Nuffield Department of Primary Care, University of Oxford, Oxford, United Kingdom
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/31730171$$D View this record in MEDLINE/PubMed
BookMark	eNo9kctu1TAQQC1URG8LGz4AeYPEJtTjOHHCDsqjlVpRtSCW0Vx7wnXl2GnsFIXv4IMJui2rWcyZs5hzxA5CDMTYSxBvQbTlCd7uTnbjb2jkE7aBVkGhpawO2EY0bVVoUcMhO0rpVgih6hqescMSdClAw4b9uSHfF0MMLsfJhZ889vyDj9Hyq4lSmifiLvArzI5CTvyHyzt-tow0ZQrJxVBck8dMll_OPrtVNG2ddXl5x2-WlGlYDw2_pntHvzgGy8-DdffOzugfpfwjZuSXlLHAgH5JLj1nT3v0iV48zGP2_fOnb6dnxcXXL-en7y8Ko0STC-gNktTbXrY91rIuG101Rlglm96oFgwopStL0KvKtI2RttVEdlsrlJWRWB6zN3vvOMW7mVLuBpcMeY-B4pw6WUIl2kpDuaKvHtB5O5DtxskNOC3d4ydX4PUeiPP4fwui-1eoWwt1-0LlX7sQhqk
CitedBy_id	crossref_primary_10_1097_HJH_0000000000003322 crossref_primary_10_1097_HJH_0000000000003164 crossref_primary_10_1097_NRL_0000000000000507 crossref_primary_10_1016_j_cct_2025_107950 crossref_primary_10_1016_j_amjmed_2020_06_015 crossref_primary_10_1097_HJH_0000000000003205 crossref_primary_10_1080_17482631_2023_2241231 crossref_primary_10_1111_jch_14341 crossref_primary_10_1136_bmjopen_2021_051180 crossref_primary_10_2196_66176 crossref_primary_10_1007_s12170_021_00672_w crossref_primary_10_20538_1682_0363_2022_1_109_120 crossref_primary_10_1016_j_cegh_2025_102183 crossref_primary_10_1007_s11906_020_01056_y crossref_primary_10_2196_33261 crossref_primary_10_1001_jama_2023_21523 crossref_primary_10_1136_bmjopen_2022_062159 crossref_primary_10_15829_1728_8800_2022_3212 crossref_primary_10_1001_jamainternmed_2022_3355 crossref_primary_10_1097_HJH_0000000000003557 crossref_primary_10_1080_17434440_2024_2375374 crossref_primary_10_1186_s12875_025_02871_5 crossref_primary_10_1111_jch_14055 crossref_primary_10_1097_MD_0000000000038179 crossref_primary_10_3390_healthcare11081069 crossref_primary_10_1038_s41440_020_00591_0 crossref_primary_10_1161_HYPERTENSIONAHA_123_22109 crossref_primary_10_1089_jwh_2022_0371 crossref_primary_10_1371_journal_pdig_0000588 crossref_primary_10_3390_diagnostics13162686 crossref_primary_10_1097_HJH_0000000000003861 crossref_primary_10_3389_fcvm_2023_1103216 crossref_primary_10_1007_s40620_025_02406_2 crossref_primary_10_1080_02813432_2023_2242711 crossref_primary_10_1002_pdi_2299 crossref_primary_10_1097_HPC_0000000000000337 crossref_primary_10_1186_s12872_024_04320_0 crossref_primary_10_1007_s11886_022_01807_0 crossref_primary_10_1186_s12889_025_22798_x crossref_primary_10_1097_NNR_0000000000000654 crossref_primary_10_3389_fpubh_2024_1378144 crossref_primary_10_3390_ijerph20032227 crossref_primary_10_1016_j_revmed_2023_01_008 crossref_primary_10_1111_jebm_12655 crossref_primary_10_1161_HYPERTENSIONAHA_125_24854 crossref_primary_10_2196_27347 crossref_primary_10_1016_j_jstrokecerebrovasdis_2021_105815 crossref_primary_10_1161_CIRCULATIONAHA_123_067597 crossref_primary_10_2196_21759 crossref_primary_10_7759_cureus_77160 crossref_primary_10_2196_53355 crossref_primary_10_1161_HYPERTENSIONAHA_120_15873 crossref_primary_10_1161_STROKEAHA_121_036885 crossref_primary_10_1002_jac5_1507 crossref_primary_10_2196_55732 crossref_primary_10_2196_72942 crossref_primary_10_1111_iwj_14227 crossref_primary_10_1093_eurheartj_ehae178 crossref_primary_10_1136_bmjopen_2021_049162 crossref_primary_10_1016_j_ajpc_2023_100632 crossref_primary_10_1016_j_mcpdig_2023_11_001 crossref_primary_10_2147_RMHP_S515019 crossref_primary_10_1097_CM9_0000000000003431 crossref_primary_10_1186_s12916_025_04278_6 crossref_primary_10_1080_02813432_2024_2332745 crossref_primary_10_1111_jch_14795
ContentType	Journal Article
Copyright	The Author(s) 2019. Published by Oxford University Press on behalf of American Journal of Hypertension, Ltd. 2019 The Author(s) 2019. Published by Oxford University Press on behalf of American Journal of Hypertension, Ltd.
Copyright_xml	– notice: The Author(s) 2019. Published by Oxford University Press on behalf of American Journal of Hypertension, Ltd. 2019 – notice: The Author(s) 2019. Published by Oxford University Press on behalf of American Journal of Hypertension, Ltd.
DBID	TOX CGR CUY CVF ECM EIF NPM 7X8
DOI	10.1093/ajh/hpz182
DatabaseName	Oxford Journals Open Access Collection Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic
DatabaseTitle	MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE MEDLINE - Academic
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: TOX name: Oxford Journals Open Access Collection url: https://academic.oup.com/journals/ sourceTypes: Publisher – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1941-7225
EndPage	251
ExternalDocumentID	31730171 10.1093/ajh/hpz182
Genre	Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review Journal Article Research Support, N.I.H., Extramural
GrantInformation_xml	– fundername: NHLBI NIH HHS grantid: R01 HL070713 – fundername: Department of Health grantid: NIHR-RP-02-12-015 – fundername: NHLBI NIH HHS grantid: R01 HL090965 – fundername: HSRD VA grantid: IK6 HX003161 – fundername: Chief Scientist Office grantid: ARPG/07/03 – fundername: Wellcome Trust grantid: 211182/Z/18/Z
GroupedDBID	--- .2P .I3 .ZR 0R~ 23M 39C 4.4 48X 53G 5GY 5RE 5WD 70F AABZA AACZT AAJKP AAMVS AAOGV AAPQZ AAPXW AARHZ AASNB AAUAY AAUQX AAVAP ABEUO ABIXL ABJNI ABKDP ABNHQ ABNKS ABOCM ABPTD ABQLI ABQNK ABWST ABXVV ABZBJ ACGFS ACUFI ACUTJ ACUTO ACYHN ADBBV ADEYI ADGZP ADHKW ADHZD ADIPN ADJQC ADOCK ADQBN ADRIX ADRTK ADVEK ADYVW ADZXQ AEGPL AEJOX AEKSI AEMDU AENEX AENZO AEPUE AETBJ AEWNT AFFZL AFIYH AFOFC AFXEN AGINJ AGQXC AGSYK AGUTN AHMBA AHXPO AJEEA AKRWK ALIPV ALMA_UNASSIGNED_HOLDINGS ALUQC APIBT ATGXG AVWKF AXUDD BAYMD BCRHZ BEYMZ BHONS BTRTY BVRKM C45 CDBKE CS3 DAKXR DILTD D~K EBS EE~ EMOBN ENERS F5P F9B FDB FECEO FLUFQ FOEOM FOTVD FQBLK G-Q GAUVT GJXCC H13 H5~ HAR HW0 HZ~ J21 KBUDW KOP KSI KSN MHKGH ML0 NGC NOMLY NOYVH O9- OAUYM OAWHX OCZFY ODMLO OJQWA OJZSN OPAEJ OVD OWPYF O~Y P2P PAFKI PEELM Q1. Q5Y ROX ROZ RPZ RUSNO RW1 RXO TEORI TJX TOX WH7 YAYTL YKOAZ YXANX AAFWJ ABDFA ABEJV ABGNP ABPQP ABVGC ADNBA AEMQT AFXAL AFYAG AGORE AHGBF AHMMS AJBYB AJNCP ALXQX CGR CUY CVF ECM EIF JXSIZ NPM 7X8
ID	FETCH-LOGICAL-c408t-1fcae27bf29fa62638758c0d428fc491c14475de1f45c98c2d97eedb64a25c2a3
IEDL.DBID	TOX
ISICitedReferencesCount	71
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000522656000007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	0895-7061 1941-7225
IngestDate	Wed Oct 01 13:54:24 EDT 2025 Mon Jul 21 05:43:20 EDT 2025 Wed Sep 11 04:47:48 EDT 2024
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	3
Keywords	blood pressure coronary heart disease diabetes hypertension stroke obesity randomized controlled trial
Language	English
License	This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. The Author(s) 2019. Published by Oxford University Press on behalf of American Journal of Hypertension, Ltd.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c408t-1fcae27bf29fa62638758c0d428fc491c14475de1f45c98c2d97eedb64a25c2a3
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3
ORCID	0000-0002-4461-8756
OpenAccessLink	https://dx.doi.org/10.1093/ajh/hpz182
PMID	31730171
PQID	2315095713
PQPubID	23479
PageCount	9
ParticipantIDs	proquest_miscellaneous_2315095713 pubmed_primary_31730171 oup_primary_10_1093_ajh_hpz182
PublicationCentury	2000
PublicationDate	2020-03-13
PublicationDateYYYYMMDD	2020-03-13
PublicationDate_xml	– month: 03 year: 2020 text: 2020-03-13 day: 13
PublicationDecade	2020
PublicationPlace	US
PublicationPlace_xml	– name: US – name: United States
PublicationTitle	American journal of hypertension
PublicationTitleAlternate	Am J Hypertens
PublicationYear	2020
Publisher	Oxford University Press
Publisher_xml	– name: Oxford University Press
SSID	ssj0004661
Score	2.5586417
SecondaryResourceType	review_article
Snippet	Abstract BACKGROUND Studies have shown that self-monitoring of blood pressure (BP) is effective when combined with co-interventions, but its efficacy varies in... Studies have shown that self-monitoring of blood pressure (BP) is effective when combined with co-interventions, but its efficacy varies in the presence of...
SourceID	proquest pubmed oup
SourceType	Aggregation Database Index Database Publisher
StartPage	243
SubjectTerms	Aged Aged, 80 and over Blood Pressure Blood Pressure Monitoring, Ambulatory Female Humans Hypertension - diagnosis Hypertension - epidemiology Hypertension - physiopathology Hypertension - therapy Male Middle Aged Multimorbidity Predictive Value of Tests Prognosis Randomized Controlled Trials as Topic Risk Factors Self Care Time Factors
Title	Self-monitoring of Blood Pressure in Patients With Hypertension-Related Multi-morbidity: Systematic Review and Individual Patient Data Meta-analysis
URI	https://www.ncbi.nlm.nih.gov/pubmed/31730171 https://www.proquest.com/docview/2315095713
Volume	33
WOSCitedRecordID	wos000522656000007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3JTsMwELWgQogL-1KWykhcrTaO09jc2Co4tFRqEb1Fjhe1CNIqTTnwHXww4ySt2CS45JZJ5LEzbzLz3iB0xkUAYSWmRBnaJAwCFomt5xM_1qHmzdAqrfJhE2GnwwcD0S2baKa_lPCFX5dPw_pw8gZAGL60XsDdnIL-_eAT-zFXRW3AY0kI4WkuQvrl1m_8tR8wMg8nrY1_vsgmWi_xIr4oHLyFlkyyjVbbZUV8B733zLMlL_nJdL_o8NjiS9eMjgviX2rwKMHdQj11ih9H2RDfQu6Z5p3r44Tk3XBG45yJC4bSeKQBmZ_j3kLjGRcFBCwTje8WBK65UXwtM4nbJpNElgonu-ihddO_uiXlpAWiWINnxLNKGhrGlgornT4NZDFcNTTkJlYx4SnP6QJq41kWKMEV1SKE4Bo3maSBotLfQ5VknJgDhAVVXDQMkwDlGAsM4A3DmoozX6kY0FgV1cAR0aTQ0oiKGrgfwdpGxdpW0encRxFsdVe_kIkZz6YRQFGANwGk1VW0XzhvYQdgkO-kfw7_Mn-E1qhLmV1Lnn-MKlk6MydoRb1mo2laQ8vhgMO1023X8l32AS3WzvU
linkProvider	Oxford University Press
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Self-monitoring+of+Blood+Pressure+in+Patients+With+Hypertension-Related+Multi-morbidity%3A+Systematic+Review+and+Individual+Patient+Data+Meta-analysis&rft.jtitle=American+journal+of+hypertension&rft.au=Sheppard%2C+J+P&rft.au=Tucker%2C+K+L&rft.au=Davison%2C+W+J&rft.au=Stevens%2C+R&rft.date=2020-03-13&rft.pub=Oxford+University+Press&rft.issn=0895-7061&rft.eissn=1941-7225&rft.volume=33&rft.issue=3&rft.spage=243&rft.epage=251&rft_id=info:doi/10.1093%2Fajh%2Fhpz182&rft.externalDocID=10.1093%2Fajh%2Fhpz182
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0895-7061&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0895-7061&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0895-7061&client=summon